Abbott Laboratories (ABT) Insider Trading & Ownership $114.23 +1.81 (+1.61%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Abbott Laboratories (NYSE:ABT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.10%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$26.43 M Get ABT Insider Trade Alerts Want to know when executives and insiders are buying or selling Abbott Laboratories stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ABT Insider Buying and Selling by Quarter Ad Behind the MarketsAn extra $2 trillion a year for this industry?We're on the cusp of an energy revolution... I'm not talking about lithium batteries, renewable energies, or nuclear energy. This 'silent energy boom' is bigger than anything we've seen before.Click here for the shocking truth Abbott Laboratories Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/12/2024Robert B FordCEOSell141,679$116.41$16,492,852.39 9/4/2024John A Jr. MccoyVPSell27$114.83$3,100.41 9/4/2024John JamesU.S. Congress Member (R-MI)Sell$114.40$1,001 - $15,0008/19/2024Josh GottheimerU.S. Congress Member (D-NJ)Buy$111.91$1,001 - $15,0007/29/2024Josh GottheimerU.S. Congress Member (D-NJ)Buy$104.78$1,001 - $15,0007/23/2024Thomas H. Kean, Jr.U.S. Congress Member (R-NJ)Buy$103.92$1,001 - $15,0007/5/2024Jared MoskowitzU.S. Congress Member (D-FL)Buy$104.02$1,001 - $15,0007/2/2024Kathy E. ManningU.S. Congress Member (D-NC)Buy$103.20$1,001 - $15,0005/10/2024Jr. Robert E FunckEVPSell10,097$104.57$1,055,843.29 5/7/2024Lisa D EarnhardtEVPSell22,852$106.25$2,428,025.00 3/1/2024Daniel Gesua Sive SalvadoriEVPSell963$118.50$114,115.50 3/1/2024John A Jr. MccoyVPSell472$118.50$55,932.00 2/23/2024Andrea F WainerEVPSell12,500$120.00$1,500,000.00 1/29/2024Andrea F WainerEVPSell42,500$112.50$4,781,250.00 (Data available from 1/1/2013 forward) ABT Insider Trading Activity - Frequently Asked Questions Who is on Abbott Laboratories's Insider Roster? The list of insiders at Abbott Laboratories includes Andrea F Wainer, Daniel Gesua Sive Salvadori, Daniel J Starks, Fernando Mateus, John A Jr. Mccoy, John F Ginascol, Joseph J Manning, Jr. Robert E Funck, Julie L Tyler, Lisa D Earnhardt, Mary K Moreland, Michael D Dale, Nancy Mckinstry, Randel William Woodgrift, Robert B Ford, and Sammy Karam. Learn more on insiders at ABT. What percentage of Abbott Laboratories stock is owned by insiders? 1.10% of Abbott Laboratories stock is owned by insiders. Learn more on ABT's insider holdings. Which Abbott Laboratories insiders have been selling company stock? The following insiders have sold ABT shares in the last 24 months: Andrea F Wainer ($9,971,403.86), Daniel Gesua Sive Salvadori ($114,115.50), Daniel J Starks ($15,941,500.00), John A Jr. Mccoy ($59,032.41), Jr. Robert E Funck ($1,055,843.29), Julie L Tyler ($26,842.40), Lisa D Earnhardt ($2,428,025.00), Randel William Woodgrift ($103,922.40), and Robert B Ford ($16,492,852.39). How much insider selling is happening at Abbott Laboratories? Insiders have sold a total of 416,687 Abbott Laboratories shares in the last 24 months for a total of $46,193,537.25 sold. Which members of congress are trading Abbott Laboratories? Josh Gottheimer (D-NJ), Thomas H. Kean, Jr. (R-NJ), Jared Moskowitz (D-FL), and Kathy E. Manning (D-NC) have bought shares of Abbott Laboratories in the last year totaling $40,000. John James (R-MI), Kathy E. Manning (D-NC), and Thomas R. Carper (D-DE) have sold shares totaling $24,000. Abbott Laboratories Key ExecutivesMr. Robert B. Ford (Age 50)Chairman of the Board, President & CEO Compensation: $4.73M1 recent tradesMr. Philip P. Boudreau (Age 51)CFO & Executive VP of Finance Compensation: $1.14MMr. Hubert L. Allen (Age 58)Executive Vice President, General Counsel and Secretary Compensation: $2MMr. Daniel Gesua Sive Salvadori (Age 45)Executive VP and Group President of Established Pharmaceuticals & Nutritional Products Compensation: $1.76MMs. Lisa D. Earnhardt (Age 54)Executive VP & Group President of Medical Devices Compensation: $1.73MMs. Sabina Ewing (Age 50)Senior VP of Business & Technology Services and Chief Information Officer Mr. Michael ComillaVice President of Investor Relations.Erica L. BattagliaVP and Chief Ethics & Compliance OfficerMs. Melissa BrotzVice President of Public Affairs & Corporate MarketingMr. Christopher J. Scoggins (Age 54)Senior Vice President of Commercial Operations, Marketing & Diabetes Care More Insider Trading Tools from MarketBeat Related Companies Intuitive Surgical Insider Transactions Stryker Insider Transactions Boston Scientific Insider Transactions Medtronic Insider Transactions Becton, Dickinson and Company Insider Transactions Edwards Lifesciences Insider Transactions IDEXX Laboratories Insider Transactions ResMed Insider Transactions DexCom Insider Transactions STERIS Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NYSE:ABT) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abbott Laboratories Please log in to your account or sign up in order to add this asset to your watchlist. Share Abbott Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
